Daily14d
Microaxial Flow Pump Lowers Medication Needs and Improves Stability in Cardiogenic Shock Patients: DanGer Shock Substudy
The findings from the substudy of the DanGer Shock randomized clinical trial indicate that the use of a Microaxial Flow Pump ...
TCTMD15d
TCT 265: Bleedings Related to Use of Microaxial Flow Pump in Cardiogenic Shock: A Secondary Analysis of Danger Shock
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Johnson & Johnson says Impella ECP met primary endpoint in high-risk PCI study
Results were presented at Transcatheter Cardiovascular Therapeutics, or TCT, 2024 conference from the first completed pivotal trial on patients ...
MassDevice15d
Johnson & Johnson has positive Impella ECP heart pump data
Johnson & Johnson MedTech reported positive data for the Abiomed Impella ECP transvalvular axial flow pump system.
EurekAlert!16d
Impella ECP pivotal study demonstrates safety, efficacy for use in high-risk PCI
Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal ...
TCTMD17d
Microaxial Flow Pump Use and Renal Outcomes in Cardiogenic Shock: An Analysis of the DanGer Shock Trial
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
News Medical25d
Exploring Ventricular Assist Devices
What are Ventricular Assist Devices? Ventricular Assist Devices (VADs) are mechanical heart pumps. 1 They use electrical and mechanical technology to support cardiac functioning by helping blood ...